0001904286-22-000002.txt : 20220801 0001904286-22-000002.hdr.sgml : 20220801 20220801171002 ACCESSION NUMBER: 0001904286-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 EFFECTIVENESS DATE: 20220801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mira1a Therapeutics, Inc. CENTRAL INDEX KEY: 0001904286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853354547 STATE OF INCORPORATION: FL FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-454401 FILM NUMBER: 221125685 BUSINESS ADDRESS: STREET 1: 855 N WOLFE STREET #623-6 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 813-369-5150 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 D 1 primary_doc.xml X0708 D LIVE 0001904286 Mira1a Therapeutics, Inc. 855 N WOLFE STREET #601 BALTIMORE MD MARYLAND 21205 813-864-2562 FLORIDA MIRA Pharmaceuticals, Inc. None Corporation true 2020 Jude Uzonwanne 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Executive Officer Adam Kaplin, MD, PhD 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Executive Officer Josh Silverman 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Director Chris Chapman, MD 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Director Dave Vorhoff 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Director Brad Kroenig 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Director Hugh McColl III 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Director Talhia Tuck, JD 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Director Paul Rivard, ESQ 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Executive Officer James McNulty, CPA 855 N Wolfe Street, Suite 601 Baltimore MD MARYLAND 21205 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-07-22 false true false 0 3000000 625000 2375000 false 8 0 0 0 false Mira1a Therapeutics, Inc. James A. McNulty, CPA James A. McNulty, CPA Chief Financial Officer 2022-08-01